Firms Petition To Down-Classify Cranial Stimulators As FDA Plans PMA Rule
This article was originally published in The Gray Sheet
Executive Summary
Product makers Electromedical Products International, Fisher Wallace Laboratories and Neuro-Fitness each argue that the devices should be reclassified from class III to class II, with special controls, rather than be subject to PMA requirements.
You may also be interested in...
Panel Recommends PMAs For Cranial Electrotherapy Stimulators
FDA’s Neurological Devices panel recommends that pre-amendment cranial electrotherapy stimulator devices should remain in class III, with PMA requirements, due to a lack of efficacy data.
FDA Seeks PMA Requirements For More Pre-Amendment Devices
FDA is proposing to require pre-market approval applications for three class III, pre-amendment device types in the cardiovascular and neurologic device spaces.
FDA Panel Endorses PMAs For Electroshock Therapy Devices
A recent vote by an FDA advisory panel favoring more stringent regulation of electroconvulsive therapy devices is not likely to jeopardize future availability of the products on the market, according the panel's chairman.